PMID: 11931469Apr 5, 2002Paper

Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles

Physics in Medicine and Biology
H Paganetti

Abstract

The dose distribution delivered in charged particle therapy is due to both primary and secondary particles. The secondaries, originating from non-elastic nuclear interactions, are of interest for three reasons. First, if fast Monte Carlo treatment planning is envisaged, the question arises whether all nuclear interaction products deliver a significant contribution to the total dose and, hence, need to be tracked. Second, there could be an enhanced relative biological effectiveness (RBE) due to low energy and/or heavy secondaries. Third, neutrons originating from nuclear interactions may deliver dose outside the target volume. The particle yield from different nuclear interaction channels as a function of proton penetration depth was studied theoretically for different proton beam energies. Three-dimensional dose distributions from primary and secondary particles were simulated for an unmodulated 160 MeV proton beam with and without including a slice of bone material and for a spread-out Bragg peak (SOBP) of 3 x 3 x 3 cm3 in water. Secondary protons deliver up to 10% of the total dose proximal to the Bragg peak of an unmodulated proton beam and they affect the flatness of the SOBP. Furthermore, they cause a dose build-up due to ...Continue Reading

References

Nov 1, 1978·International Journal of Radiation Oncology, Biology, Physics·P J KliaugaH H Rossi
Nov 1, 1978·International Journal of Radiation Oncology, Biology, Physics·E J HallY M Lam
May 1, 1991·Medical Physics·P L PettiB A Ludewigt
Dec 1, 1986·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·A PerrisE G Sideris
Jul 1, 1974·Physics in Medicine and Biology·R Katz, S C Sharma
Jan 1, 1995·Acta Oncologica·M Lundell, L E Holm
Jun 1, 1995·Physics in Medicine and Biology·K R RussellA Montelius
Jan 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H M WareniusJ H Peacock
May 1, 1996·International Journal of Radiation Biology·F A CucinottaR Katz
Jun 1, 1996·International Journal of Radiation Biology·M FolkardB D Michael
Jul 15, 1996·International Journal of Radiation Oncology, Biology, Physics·P L Petti
Aug 1, 1996·Physics in Medicine and Biology·L HongM Urie
Sep 1, 1996·Physics in Medicine and Biology·H Paganetti, T Schmitz
Feb 1, 1997·International Journal of Radiation Oncology, Biology, Physics·H PaganettiH W Müller-Gärtner
Jan 30, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S AgosteoG Tosi
Sep 29, 2001·International Journal of Radiation Biology·H Paganetti, M Goitein

❮ Previous
Next ❯

Citations

Sep 8, 2010·Radiological Physics and Technology·Yuka MatsuzakiYoshiaki Kiyanagi
May 17, 2011·Australasian Physical & Engineering Sciences in Medicine·Z RiaziR Sadighi-Bonabi
May 23, 2002·International Journal of Radiation Oncology, Biology, Physics·Harald PaganettiHerman D Suit
May 20, 2011·Radiation Protection Dosimetry·Y Chen, S Ahmad
Apr 17, 2010·American Journal of Clinical Oncology·Yi Rong, James Welsh
May 30, 2003·Medical Physics·Jan J Wilkens, Uwe Oelfke
Aug 9, 2003·Medical Physics·H Paganetti, B Gottschalk
Sep 21, 2004·Medical Physics·Matthias Fippel, Martin Soukup
Mar 26, 2005·Medical Physics·Jan J Wilkens, Uwe Oelfke
Jan 7, 2014·Medical Physics·Edmond SterpinHugo Bouchard
Dec 11, 2013·Medical Physics·Rebecca GrünMichael Scholz
Feb 24, 2010·Medical Physics·Ben ClasieAnatoly Rosenfeld
Jan 26, 2010·Medical Physics·Stephen DowdellAnatoly Rosenfeld
Oct 23, 2010·Medical Physics·Gabriel O SawakuchiUwe Titt
May 16, 2007·Medical Physics·Hongyu JiangHarald Paganetti
Sep 6, 2014·Journal of Medical Physics·Keyvan Jabbari, Jan Seuntjens
Feb 17, 2015·Cancers·Francesco Tommasino, Marco Durante
Jul 6, 2010·International Journal of Radiation Biology·Ivan PetrovićGiacomo Cuttone
Oct 20, 2010·International Journal of Radiation Biology·Ariungerel GerelchuluunKoji Tsuboi
Nov 11, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Erik RoelofsUNKNOWN ROCOCO Consortium
Mar 6, 2012·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·L Al-SulaitiH Palmans
Sep 19, 2009·Zeitschrift für medizinische Physik·Zdenek Morávek, Ludwig Bogner
Aug 7, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jonas JohanssonBengt Glimelius
Aug 21, 2012·International Journal of Radiation Biology·Zhengshan HongKoji Tsuboi
Jan 13, 2015·Radiation and Environmental Biophysics·S ReinhardtK Parodi
Sep 18, 2012·Radiation Oncology Journal·Seo Hyun Park, Jin Oh Kang
Oct 8, 2003·Technology in Cancer Research & Treatment·H Paganetti
Mar 13, 2018·Journal of Radiation Research·Anussara PrayongratHiroki Shirato

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.